ClinicalTrials.gg
CompletedNCT01613781Updated Dec 25, 2013

Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression Surgery

An interventional study of TOF count-guided partial NMB and T1/Tc guided partial NMB in Hemifacial Spasm, Microvascular Decompression and Neuromuscular Blockade, sponsored by Samsung Medical Center. Completed at 1 site in Korea, Republic of. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2013-12-25.

Sponsored by Samsung Medical Center · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
61
Allocation
Randomized
Ages
20 Years to 70 Years
Sex
All
01

Study summary

There have been reports of monitoring LSR during MVD surgery helps predicting the clinical outcome of MVD. However, there have been no evidence of which degree of partial neuromuscular blockade should be performed during LSR monitoring under sevoflurane anesthesia. Therefore, the investigators performed a randomized controlled trial to evaluate the effect of different degree of partial neuromuscular blockade on the LSR monitoring for MVD surgery.

Read the detailed description

Hemifacial spasm develops by vascular compression of facial nerve at the root exit zone from brain stem. Microvascular decompression (MVD) is known for its curative treatment. Lateral spread response (LSR) is a kind of pathologic electromyographic (EMG) wave form which develops when facial nerve is compressed by vessel. There have been reports of monitoring LSR during MVD surgery helps predicting the clinical outcome of MVD.

As neuromuscular blockade during LSR monitoring decreases the amplitude of EMG, partial neuromuscular blockade is usually maintained during general anesthesia for MVD. However, there have been no evidence of which degree of partial neuromuscular blockade should be performed during LSR monitoring under sevoflurane anesthesia. Therefore, the investigators performed a randomized controlled trial to evaluate the effect of different degree of partial neuromuscular blockade on the LSR monitoring for MVD surgery.

02

Conditions studied

  • Hemifacial Spasm
  • Microvascular Decompression
  • Neuromuscular Blockade

Browse trials for

Keywords

  • hemifacial spasm
  • microvascular decompression
  • neuromuscular blockade
  • electromyography
03

In context

Hemifacial Spasm

23 studies on the registry are indexed under Hemifacial Spasm; 3 are open to participants now.

This study's enrollment of 61 is close to the median of 61 across 11 interventional studies indexed under Hemifacial Spasm.

Browse Hemifacial Spasm studies →

Lead sponsor

Samsung Medical Center is the lead sponsor of 1,011 studies on the registry; 152 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Those who undergo microvascular decompression with sevoflurane anesthesia by diagnosis of hemifacial spasm in our institution

Exclusion criteria

Exclusion Criteria:

  • Patients were excluded from the study if they had any of following: severe cardiopulmonary disorder with hemodynamic unstability (pulmonary hypertension, cardiomyopathy, mechanical ventilation, physical status III or more), severe hepatic or renal disease.
  • Those who can not undergo MEP monitoring due to central or peripheral neuromuscular disease, e.g. cerebral palsy, myasthenia gravis, acute spinal injury, neurologic shock
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
61 participants (actual)

Study arms

  • Active comparator
    T1/Tc amplitude-guided group

    Using partial neuromuscular blockade to maintain T1/Tc amplitude of 50%, T1/Tc amplitude measured by the neuromuscular transmission module (NMT)

    Other: T1/Tc guided partial NMB

  • Active comparator
    TOF count-guided group

    Using partial neuromuscular blockade to maintain train-of-four response of two, TOF response measured by the neuromuscular transmission module (NMT module)

    Other: TOF count-guided partial NMB

Interventions

  • OtherTOF count-guided partial NMB

    TOF count-guided partial NMB Using partial neuromuscular blockade to maintain train-of-four response of two, TOF response measured by the neuromuscular transmission module (NMT module)

    Also known as: neuromuscular transmission module (NMT module)

  • OtherT1/Tc guided partial NMB

    Using partial neuromuscular blockade to maintain T1/Tc amplitude of 50%, T1/Tc amplitude measured by the neuromuscular transmission module (NMT)

    Also known as: neuromuscular transmission module (NMT)

06

What researchers measure

Primary outcomes

  1. Lateral spread response

    Lateral spread response of electromyography measured by electrophysiologist at baseline (30 min after anesthetic induction)

    Time frame: baseline (30 min after anesthetic induction)

  2. Lateral spread response

    Lateral spread response of electromyography measured by electrophysiologist before dura opening

    Time frame: before dura opening (45 minute after anesthetic induction)

  3. Lateral spread response

    Lateral spread response of electromyography measured by electrophysiologist after dura opening (one hour after anesthetic induction)

    Time frame: after dura opening (60 min after anesthetic induction)

  4. Lateral spread response

    Lateral spread response of electromyography measured by electrophysiologist before facial nerve decompression (90 minutes after anesthetic induction)

    Time frame: before facial nerve decompression (90 minutes after anesthetic induction)

  5. Lateral spread response

    Lateral spread response of electromyography measured by electrophysiologist after facial nerve decompression (2 hour after anesthetic induction)

    Time frame: after facial nerve decompression (120 min after anesthetic induction)

  6. Lateral spread response

    Lateral spread response of electromyography measured by electrophysiologist after dura closure (150 min after anesthetic induction)

    Time frame: after dura closure (150 min after anesthetic induction)

Secondary outcomes

  1. Train-of-four response

    Train-of-four response to ulnar nerve electrical stimulation measured by NMT module at six time-points; Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

    Time frame: Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

  2. T1/Tc amplitude

    T1/Tc amplitude as a reponse to ulnar nerve stimulation measured by NMT module at six time points; Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

    Time frame: Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

  3. incidence of patients' spontaneous movements or respiration

    incidence of patients' spontaneous movements or respiration measured by anesthesiologists or reported by surgeon at six time points; Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

    Time frame: Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

  4. Mean blood pressure (mmHg)

    mean blood pressure measured by anesthesiologists at six time points; Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

    Time frame: Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

  5. heart rate (beats/min)

    heart rate measured by anesthesiologists at six time points; Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

    Time frame: Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

  6. pulse oximetry (oxygen saturation, %)

    pulse oximetry measured by anesthesiologists at six time points; Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

    Time frame: Baseline (30min), Before dura open (45 min), After dura open (60 min), Before decompression (90 min), After decompression (120 min), After dura close (150 min after anesthetic induction)

07

Study locations

1 site
  • Samsung Medical Center
    Seoul, 135-710, Korea, Republic of
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 25, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01613781
Responsible party
Jeong Jin Lee (Professor, Samsung Medical Center) — Principal investigator
First posted
Jun 7, 2012
Start date
Jun 2012
Primary completion
Feb 2013
Completion
Feb 2013
Last update
Dec 25, 2013

Study contacts

Jeong Jin Lee, MD, PhD
principal investigator · Samsung Medical Center
Won Ho Kim, MD
principal investigator · Samsung Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion